$7.32
0.253.54%
Últ. Act.: Oct 23, 4:00 PM
Maravai LifeSciences (MRVI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Maravai LifeSciences (MRVI) publicó su última previsión de agosto 6, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $205M - $215M para el período.
En comparación con la previsión anterior, Maravai LifeSciences mantenido redujo su previsión de ingresos desde un rango anterior de $205M - $215M.
Maravai LifeSciences ha emitido 15 actualizaciones de orientación entre el noviembre 2, 2022 y el agosto 6, 2026. During this period, the company raised its outlook 2 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.05 | $-0.05 | $-0.08 | $-0.08 |
| Actual | $-0.02 | $0.01 | $-0.04 | $-0.08 |
| Surprise | +60.0% | +120.0% | +50.0% | 0.00% |
| Revenue | ||||
| Estimate | $48.8M | $53.3M | $49.1M | $49.9M |
| Actual | $51.4M | $65.8M | $49.9M | $41.6M |
| Surprise | +5.45% | +23.5% | +1.47% | -16.5% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.06 | $-0.05 | $0.01 | $-0.02 |
| Revenue | ||||
| Consensus | $43.4M | $51.0M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.02 | $-0.05 | 60.0 % |
| Q1 | May 7, 2026 | $0.01 | $-0.05 | 120.0 % |
| Q4 | Feb 25, 2026 | $-0.04 | $-0.08 | 50.0 % |
| Q3 | Nov 6, 2025 | $-0.08 | $-0.08 | 0.00 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $51.44M | $48.78M | 5.45 % |
| Q1 | May 7, 2026 | $65.84M | $53.31M | 23.5 % |
| Q4 | Feb 25, 2026 | $49.87M | $49.14M | 1.47 % |
| Q3 | Nov 6, 2025 | $41.63M | $49.88M | -16.5 % |